References
Demirci H, Shields CL, Karatza EC, Shields JA (2008) Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases. Ophthalmology 115:1626–1631, 1631.e1–3
Rasmussen P, Sjo LD, Prause JU, Ralfkiaer E, Heegaard S (2009) Mantle cell lymphoma in the orbital and adnexal region. Br J Ophthalmol 93:1047–1051
Olioso P, Giancola R, Di Riti M, Contento A, Accorsi P, Iacone A (2009) Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial. Hematol Oncol 27:130–139
Tita-Nwa F, Moldenhauer G, Herbst M, Kleist C, Ho AD, Kornacker M (2007) Cytokine-induced killer cells targeted by the novel bispecific antibody CD19xCD5 (HD37xT5.16) efficiently lyse B-lymphoma cells. Cancer Immunol Immunother 56:1911–1920
Helms MW, Prescher JA, Cao YA, Schaffert S, Contag CH (2010) IL-12 enhances efficacy and shortens enrichment time in cytokine-induced killer cell immunotherapy. Cancer Immunol Immunother 59:1325–1334
Reitter S, Neumeister P, Beham-Schmid C, Emberger W, Strunk D, Brezinschek R, Linkesch W, Schmidt HH (2010) A case of generalized MALT lymphoma with IgM paraproteinemia and peripheral blood involvement. Ann Hematol 89:213–214
Acknowledgments
This work was supported by the special funds for Central Health Projects (no. B2009B115).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, SX., Zhu, HL., Guo, B. et al. Treatment for orbital diffuse large B-cell lymphoma in an elderly patient by autologous cytokine-induced killer cells. Ann Hematol 91, 639–640 (2012). https://doi.org/10.1007/s00277-011-1301-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-011-1301-5